Financhill
Buy
74

CDTX Quote, Financials, Valuation and Earnings

Last price:
$60.03
Seasonality move :
-8.92%
Day range:
$54.52 - $61.60
52-week range:
$10.14 - $61.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
40.98x
P/B ratio:
9.36x
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
374.37%
Market cap:
$1.3B
Revenue:
$1.3M
EPS (TTM):
-$29.47

Earnings Data

Next earnings date for CDTX
Aug 13
2025
Most recent earnings per share
-$1.66
Beat by $1.81
(May 8/2025)
Consensus Estimate
-$3.47
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CDTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -- -$1.66 --
08/13/2025 Q2 -- -- -- -$1.83 --
05/08/2025 Q1 -- -- -$1.66 -$3.47 $1.81
03/06/2025 Q4 $240K -- -$5.37 -$3.67 -$1.70
11/07/2024 Q3 $433.3K -- -$2.45 -$5.44 $2.99
08/13/2024 Q2 $1.3M $302K -$19.99 -$3.15 -$16.85
05/15/2024 Q1 $9M $973K -$2.28 -$2.39 $0.11
03/22/2024 Q4 $11.5M $2.8M -$0.69 -$2.07 $1.38
11/02/2023 Q3 $8.1M $9.2M -$2.02 -$3.00 $0.98
08/03/2023 Q2 $11.5M $5.1M -$3.02 -$2.60 -$0.42
05/11/2023 Q1 -- $26.1M $0.60 -- --
03/23/2023 Q4 -- $10.4M -$3.80 -- --
11/03/2022 Q3 -- $40.7M $3.40 -- --
08/09/2022 Q2 -- $6.2M -$3.80 -- --
05/11/2022 Q1 -- $7.1M -$5.40 -- --
03/07/2022 Q4 -- $7.2M -$5.20 -- --
11/10/2021 Q3 -- $7.1M -$7.40 -- --
08/12/2021 Q2 -- $32.9M $3.60 -- --
05/13/2021 Q1 -- $2.4M -$7.80 -- --
02/25/2021 Q4 -- $3.7M -$9.80 -- --
11/05/2020 Q3 -- $2.4M -$8.20 -- --
08/13/2020 Q2 -- $3.4M -$9.00 -- --
05/13/2020 Q1 -- $2.5M -$9.20 -- --
03/04/2020 Q4 -- $1.8M -$8.40 -- --
11/07/2019 Q3 -- $19.1M $1.60 -- --
08/08/2019 Q2 -- -- -$9.40 -- --
05/09/2019 Q1 -- -- -$11.60 -- --
02/28/2019 Q4 -- -- -$8.80 -- --
11/08/2018 Q3 -- -- -$9.80 -- --
08/08/2018 Q2 -- -- -$22.60 -- --
05/10/2018 Q1 -- -- -$16.00 -- --
02/27/2018 Q4 -- -- -$13.80 -- --
11/08/2017 Q3 -- -- -$14.60 -- --
08/09/2017 Q2 -- -- -$19.80 -- --
03/31/2017 Q1 -- -- -$16.00 -- --
03/17/2017 Q4 -- -- -$17.60 -- --
11/10/2016 Q3 -- -- -$17.60 -- --
08/11/2016 Q2 -- -- -$17.00 -- --
05/19/2016 Q1 -- -- -$14.20 -- --
03/21/2016 Q4 -- -- -$14.40 -- --
11/17/2015 Q3 -- -- -$13.40 -- --

Cidara Therapeutics Earnings Questions

  • How Much did Cidara Therapeutics Generate in Revenue Last Quarter?

    Cidara Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Cidara Therapeutics Beat Earnings Last Quarter?

    Cidara Therapeutics announced earnings per share of -$1.66 which represents a beat of analyst forecast a -$3.47 per share.

  • Is Cidara Therapeutics Profitable?

    Cidara Therapeutics reported $6.9M that represents $1.52 per share over the last quarter.

  • What is the Analyst Consensus for Cidara Therapeutics EPS Next Year?

    Cidara Therapeutics's earnings are forecast to decrease from -$26.75 per share to -$22.94 per share next year representing a decrease of -73.18%.

  • When is Cidara Therapeutics's Earnings Date?

    Cidara Therapeutics's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock